{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:06:37Z","timestamp":1751083597778,"version":"3.41.0"},"reference-count":15,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2024,4,13]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to investigate the association between financial toxicity (FT) and the health-related quality of life profile of long-term survivors of acute promyelocytic leukaemia (APL) treated within a universal healthcare system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We evaluated FT using the financial difficulties item of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). We also compared the prevalence of clinically important problems and symptoms between the survivors of APL with or without FT, using evidence-based thresholds for the EORTC QLQ-C30. A multivariable logistic regression analysis was performed to explore potential risk factors associated with FT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 352 long-term survivors of APL, with a median age of 53.9 years and a median time since diagnosis of 12.2 years, were analysed. Of these, 71 (20.2%) reported having FT. The prevalence of clinically important problems and symptoms was generally higher across most EORTC QLQ-C30 scales for those survivors who reported FT. The three largest differences between patients with and without FT were observed for emotional functioning (+35.4\u2009percentage points), dyspnoea (+33.1\u2009percentage points) and physical functioning (+27.0\u2009percentage points). The presence of FT was independently associated with having comorbidities and not receiving a salary\/pension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These findings suggest that even many years after being diagnosed, one-fifth of long-term survivors of APL experience FT. Interventions to assist with employment may be critical to minimise the risk of FT in the most vulnerable survivors.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2024-004924","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T17:15:14Z","timestamp":1715274914000},"page":"530-534","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemia"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-3095","authenticated-orcid":false,"given":"Francesco","family":"Sparano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Voso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes M","family":"Giesinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Fazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Vignetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5065-5166","authenticated-orcid":false,"given":"Fabio","family":"Efficace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"2025062705050651000_15.4.530.1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13195015","article-title":"Patient-reported financial distress in cancer: a systematic review of risk factors in universal Healthcare systems","volume":"13","author":"Pauge","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025062705050651000_15.4.530.2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/OP.23.00434","article-title":"Financial toxicity and health-related quality of life profile of patients with hematologic malignancies treated in a universal health care system","volume":"20","author":"Sparano","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"2025062705050651000_15.4.530.3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood.V88.4.1390.bloodjournal8841390","article-title":"AIDA (all-Trans retinoic acid + Idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto (GIMEMA) pilot study","volume":"88","author":"Avvisati","year":"1996","journal-title":"Blood"},{"key":"2025062705050651000_15.4.530.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300874"},{"key":"2025062705050651000_15.4.530.5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2023-185121","article-title":"Long-term outcome of 1296 patients with newly diagnosed with APL: a harmony alliance study","volume":"142","author":"Guarnera","year":"2023","journal-title":"Blood"},{"key":"2025062705050651000_15.4.530.6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41375-018-0325-4","article-title":"Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia","volume":"33","author":"Efficace","year":"2019","journal-title":"Leukemia"},{"key":"2025062705050651000_15.4.530.7","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/bloodadvances.2021004649","article-title":"Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic Trioxide vs chemotherapy","volume":"5","author":"Efficace","year":"2021","journal-title":"Blood Adv"},{"key":"2025062705050651000_15.4.530.8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2025062705050651000_15.4.530.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.10.003"},{"key":"2025062705050651000_15.4.530.10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025062705050651000_15.4.530.11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jval.2019.06.004","article-title":"Validation of the European Organisation for research and treatment of cancer quality of life questionnaire core 30 summary score in patients with hematologic malignancies","volume":"22","author":"Efficace","year":"2019","journal-title":"Value Health"},{"key":"2025062705050651000_15.4.530.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-699439"},{"key":"2025062705050651000_15.4.530.13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11764-018-0723-7","article-title":"Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors","volume":"13","author":"Pearce","year":"2019","journal-title":"J Cancer Surviv"},{"key":"2025062705050651000_15.4.530.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05719-z"},{"key":"2025062705050651000_15.4.530.15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.20.03746","article-title":"Impact of pain on employment and financial outcomes among cancer survivors","volume":"40","author":"Halpern","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2024-004924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T12:05:20Z","timestamp":1751025920000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2024-004924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,6,27]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/spcare-2024-004924"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2024-004924","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"type":"print","value":"2045-435X"},{"type":"electronic","value":"2045-4368"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}